Mitochondrial complex I dysfunction alters the balance of soluble and membrane-bound TNF during chronic experimental

Ainize Peña-Cearra1,2, Miguel Angel Pascual-Itoiz1, Jose Luis Lavín1,3

  • 1CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Building 801A, 48160, Derio, Spain.

Scientific Reports
|June 15, 2022
PubMed

Insights

Mitochondrial protein MCJ deficiency unexpectedly reduces inflammatory bowel disease severity in chronic models by altering microbial composition and increasing TACE activity. This suggests MCJ influences gut inflammation adaptation.

Area of Science:

  • Immunology
  • Gastroenterology
  • Mitochondrial Biology

Background:

  • Inflammatory bowel disease (IBD) is a complex chronic condition influenced by genetic, environmental, microbial, and immune factors.
  • MCJ is a mitochondrial protein regulating macrophage metabolism and bacterial response.
  • Previous studies indicated MCJ deficiency exacerbates acute DSS-induced colitis.

Purpose of the Study:

  • To investigate the role of MCJ in chronic inflammatory bowel disease models.
  • To explore the impact of MCJ deficiency on TACE activity and microbial composition during chronic inflammation.

Main Methods:

  • Utilized a chronic murine model of DSS-induced colitis.
  • Assessed TACE activity in MCJ-deficient mice.
  • Analyzed gut microbial composition and diversity using sequencing.

Main Results:

  • MCJ-deficient mice exhibited augmented TACE activity in chronic inflammation.
  • This TACE activity correlated with a milder disease phenotype and increased soluble TNF.
  • MCJ deficiency led to increased gut microbial alpha diversity and reduced Ruminococcus gnavus.

Conclusions:

  • MCJ plays a role in the dynamic metabolic adaptation of colon tissue to chronic inflammation.
  • MCJ deficiency can lead to beneficial changes in microbial composition and TACE activity, potentially mitigating chronic IBD.
  • Mitochondrial function is a key regulator of the host-microbe-inflammation axis in IBD.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
229
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
370
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
536
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
308
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K